arginyl-glycyl-aspartic acid has been researched along with Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, RJ; Hoekman, JD; Srivastava, P | 1 |
| Chen, L; Chen, Z; Wang, F; Zhang, R; Zhu, L | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Pain
| Article | Year |
|---|---|
Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.
Topics: Acylation; Aerosols; Analgesics, Opioid; Animals; Central Nervous System; Fentanyl; Human Umbilical Vein Endothelial Cells; Humans; Integrins; Liposomes; Nanoparticles; Oligopeptides; Pain; Peptides; Rats | 2014 |
RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line; Cisplatin; Drug Delivery Systems; Humans; Infrared Rays; Liposomes; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pain; Particle Size; Prostatic Neoplasms; Quantum Dots; Sulfides; Survival Analysis | 2014 |